Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA Labs Plunges 3%; BSE HEALTHCARE Index Down 0.5%
Tue, 26 Nov 12:33

IPCA Labs Plunges 3%; BSE HEALTHCARE Index Down 0.5%Image source: bluebay2014/www.istockphoto.com

IPCA Labs share price has plunged 3% and is presently trading at Rs 1,561.1.

Meanwhile, the BSE HEALTHCARE index is at 43,168.5 (down 0.5%).

Among the top losers in the BSE HEALTHCARE index today are POLY MEDICURE (down 7.2%) and FORTIS HEALTHCARE (down 3.6%).

CAPLIN POINT (up 5.5%) and MAX HEALTHCARE INSTITUTE (up 3.8%) are among the top gainers today.

Over the last one year, IPCA Labs has moved up from Rs 1,089.1 to Rs 1,561.1, registering a gain of Rs 472.0 (up 43.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,918.9 to 43,168.5, registering a gain of 44.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 168.2%), SUVEN PHARMACEUTICALS (up 110.7%) and Glenmark Pharma (up 95.6%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,861.8 (down 0.3%).

The top losers among the BSE Sensex today are MUNDRA PORT & SEZ (down 3.3%) and Ultratech Cement (down 2.6%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,148.1 (down 0.3%). Adani Enterprises and MUNDRA PORT & SEZ are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,023.2 to 79,861.8, registering a gain of 13,838.5 points (up 21.0%).

IPCA Labs Financial Update...

IPCA Labs net profit grew 78.6% YoY to Rs 2,454 million for the quarter ended September 2024, compared to a profit of Rs 1,374 million a year ago. Net sales rose 15.8% to Rs 23,549 million during the period as against Rs 20,340 million in July-September 2023.

For the year ended March 2024, IPCA Labs reported 7.6% increase in net profit to Rs 5,292 million compared to net profit of Rs 4,919 million during FY23. Revenue of the company grew 23.6% to Rs 76,198 million during FY24.

The current Price to earnings ratio of IPCA Labs, based on rolling 12 month earnings, stands at 59.1.


Equitymaster requests your view! Post a comment on "IPCA Labs Plunges 3%; BSE HEALTHCARE Index Down 0.5%". Click here!